ResultsIQ

ResultsIQ › Latest results › Wanbury Limited

Wanbury Limited Q2 FY27 results press release summary

NSE: WANBURY · BSE: 524212

Results press release of 6 Nov 2026, summarised by AI from the filing.

Wanbury Q2 FY27 revenue ₹182.9 cr (+14.3% YoY) with EBITDA margin at 14.3%, and management expects better topline and profitability in H2 FY27.

Key takeaways

  1. Q2 revenue Revenue from Operations ₹182.9 cr (Q2 FY26: ₹160.1 cr, +14.3%; Q1 FY27: ₹165.6 cr, +10.5%), recovering from the West Asia crisis disruption.
  2. H2 guidance Management expects better topline and profitability in the second half of the year, with margins recovering fully as pass-through completes.
  3. Regulatory gains Nine USFDA "No DMF Deficiency" letters for Metformin HCl, a Rivaroxaban CEP from EDQM and a TGA GMP certificate for Tanuku open new markets.
  4. Input costs Solvent and crude-linked raw material prices stayed elevated after the West Asia crisis, keeping gross margin below Q2 FY26's 58.2%.

Original filing on BSE

Wanbury Limited Q2 FY27 results

As filed: Revenue ₹183 cr (+14% year on year), EBITDA ₹26.1 cr (0% year on year), PAT ₹11.9 cr (−21% year on year), EBITDA margin 14.3% (−199 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹166 cr (+2% year on year), EBITDA ₹16.2 cr (−38% year on year), PAT ₹3.2 cr (−75% year on year), EBITDA margin 9.8% (−614 bps). Score 28 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 614 bps year on year. Profit fell 85% from last quarter. Share price after the results: −5.1% in 30 days (Nifty 500: −3.1%).
  • Q4 FY26: Revenue ₹165 cr (−4% year on year), EBITDA ₹29.9 cr (+3% year on year), PAT ₹21.7 cr (−1% year on year), EBITDA margin 18.1% (+128 bps). Score 29 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin rose 128 bps year on year. Tax rate -43%. Share price after the results: −11.1% in 27 days (Nifty 500: +2.0%).
  • Q3 FY26: Revenue ₹162 cr (+22% year on year), EBITDA ₹26.7 cr (+105% year on year), PAT ₹15.8 cr (+300% year on year), EBITDA margin 16.4% (+666 bps). Score 69 of 100, Above trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was above it. EBITDA margin rose 666 bps year on year. Tax rate 1%. Share price after the results: −3.5% in 29 days (Nifty 500: −4.0%).
  • Q2 FY26: Revenue ₹160 cr (−1% year on year), EBITDA ₹26.0 cr (+37% year on year), PAT ₹15.0 cr (+88% year on year), EBITDA margin 16.3% (+445 bps). Score 60 of 100, In line with trend. Revenue and EBITDA growth were below the company's own trend; profit growth was in line with it. EBITDA margin rose 445 bps year on year. Tax rate 0%. Profit rose ₹7.0 cr on a year ago, more than the ₹1.0 cr it added the year before. Share price after the results: −4.7% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹163 cr (+24% year on year), EBITDA ₹26.0 cr (+136% year on year), PAT ₹13.0 cr (+300% year on year), EBITDA margin 16.0% (+755 bps). Score 73 of 100, Above trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was above it. EBITDA margin rose 755 bps year on year. Tax rate 0%. Revenue fell 5% from last quarter. Share price after the results: +2.8% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹172 cr (+24% year on year), EBITDA ₹29.0 cr (+71% year on year), PAT ₹20.0 cr (−41% year on year), EBITDA margin 16.9% (+463 bps). Score 71 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin rose 463 bps year on year. Tax rate -5%. Consolidated profit -41% but standalone +150%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +12.5% in 29 days (Nifty 500: +0.5%).
  • Q3 FY25: Revenue ₹133 cr (−9% year on year), EBITDA ₹13.0 cr (−35% year on year), PAT ₹1.0 cr (−90% year on year), EBITDA margin 9.8% (−392 bps). Score 8 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 392 bps year on year. Other income 100% of PBT. Tax rate 0%. Revenue fell 17% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Wanbury Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.